-->

Libellés

google.com, pub-5384162920578862, DIRECT, f08c47fec0942fa0 google.com, pub-5384162920578862, DIRECT, f08c47fec0942fa0

FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations

FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations
Advisors to the Food and Drug Administration have recommended unanimously that the agency approve the Alzheimer’s drug donanemab.

جديد قسم : https://iptvcccamkodismarttv.blogspot.com/